From bench to business
What does it take to turn Max Delbrück Center research into a startup? Meet Klaas Yperman, our very first Entrepreneur-in-Residence. Yperman has won a Helmholtz Enterprise grant to develop a roadmap for turning compounds discovered in the Lewin lab into a drug to treat neuropathic pain.